Application 020781

Type: NDA
Sponsor: NOVARTIS

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ZOFRAN ODT	ONDANSETRON	TABLET, ORALLY DISINTEGRATING;ORAL	4MG	Yes	No
002	ZOFRAN ODT	ONDANSETRON	TABLET, ORALLY DISINTEGRATING;ORAL	8MG	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020781-001	ZOFRAN ODT	ONDANSETRON	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27
N020781-002	ZOFRAN ODT	ONDANSETRON	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020781-001	ZOFRAN ODT	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N020781-002	ZOFRAN ODT	8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020781-001	ZOFRAN ODT	4MG	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020781-002	ZOFRAN ODT	8MG	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020781-001	ZOFRAN ODT	4MG	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N020781-002	ZOFRAN ODT	8MG	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020781-001	ZOFRAN ODT	4MG	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N020781-002	ZOFRAN ODT	8MG	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1999-01-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020781-001	ZOFRAN ODT	4MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD	1999-01-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020781-002	ZOFRAN ODT	8MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1999-01-27	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N020781-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020781-002	AB	1	`74a2ff9319b5…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020781-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020781-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020781-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020781-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020781-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020781-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020781-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020781-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020781-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020781-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020781-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020781-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020781-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020781-002	AB	1	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 7 · 137 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ondansetron	ONDANSETRON	Cardinal Health 107, LLC	1b9c2d9f-62a8-4d26-a041-a598bc59e300	2026-06-26	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Cardinal Health 107, LLC	3c34ca82-9705-4784-be7c-8b50351d14fc	2026-06-12	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Preferred Pharmaceuticals Inc.	e87a5803-e872-43f7-8a15-79aa236e8c07	2026-06-11	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	BluePoint Laboratories	ed1132ec-c2cd-4646-b69d-26663bb937a4	2026-06-10	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	American Health Packaging	92b96072-e8f2-4fd6-aaa0-b73fed214319	2026-06-01	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Hospira, Inc.	d62cd60b-f87e-4825-bead-1d18bbc4e480	2026-05-23	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Hospira, Inc.	6a11f61b-2318-4382-2b91-4366e4bb53fa	2026-05-22	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
ONDANSETRON	ONDANSETRON	A-S Medication Solutions	b60074e5-8e77-4dc0-9244-4205e4adbaef	2026-05-11	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Bryant Ranch Prepack	c83821ad-822e-47dc-8108-612312cf3a16	2026-05-04	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Civica, Inc.	70437694-0341-4f3b-824c-06843403443f	2026-04-19	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Hikma Pharmaceuticals USA Inc.	97713356-f42b-4a67-95f6-561afa68c0c2	2026-04-16	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Bryant Ranch Prepack	40258e4b-5e67-46c0-8ef0-3e8bfe36ba11	2026-04-16	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Sportpharm LLC	98c1413c-ff7f-4554-9e9f-289038b39ca6	2026-04-14	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	Hikma Pharmaceuticals USA Inc.	c29ca6df-621d-44b6-98fc-b48666573366	2026-04-09	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	NuCare Pharmaceuticals,Inc.	5bacb621-1261-25d9-e053-2991aa0afa3b	2026-04-08	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	PAI Holdings, LLC dba PAI Pharma	68a4d845-0c1c-4867-bfca-c0fb11dc93cd	2026-03-31	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
ONDANSETRON	ONDANSETRON	HF Acquisition Co LLC, DBA HealthFirst	4dcd1e4c-6a9c-7ac6-e063-6394a90a39bf	2026-03-24	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	JVET PHARMACEUTICALS LLC	95ca0d81-a0a8-441d-820e-cb6624018a15	2026-03-23	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
Ondansetron	ONDANSETRON	REMEDYREPACK INC.	36592150-7e19-474c-9f96-cc8341e28b5d	2026-03-20	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON
ONDANSETRON	ONDANSETRON	Direct Rx	b38feff2-900a-4e0c-8260-8f090edbc0bc	2026-03-17	Warnings, Adverse reactions	Name fallback generic name: ONDANSETRON

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0078-0679	ZOFRAN	ondansetron hydrochloride	Novartis Pharmaceuticals Corporation	NDA	Current
0078-0679	ZOFRAN	ondansetron hydrochloride	Novartis Pharmaceuticals Corporation	NDA	Current
0078-0680	ZOFRAN	ondansetron hydrochloride	Novartis Pharmaceuticals Corporation	NDA	Current
0078-0680	ZOFRAN	ondansetron hydrochloride	Novartis Pharmaceuticals Corporation	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
82444	SUPPL	2025-06-04
82443	SUPPL	2025-06-03
69073	SUPPL	2021-10-22
69056	SUPPL	2021-10-21
67248	SUPPL	2021-04-29
67242	SUPPL	2021-04-29
54223	SUPPL	2018-05-17
49978	SUPPL	2017-10-06
49964	SUPPL	2017-10-06
45881	SUPPL	2016-11-10
45877	SUPPL	2016-11-10
45486	SUPPL	2016-09-30
25822	SUPPL	2014-09-23
13429	SUPPL	2014-09-22
3345	SUPPL	2013-12-13
35350	SUPPL	2013-12-11
44070	ORIG	2011-12-20
35349	SUPPL	2011-09-16
25821	SUPPL	2011-09-16
13428	SUPPL	2010-09-29
3344	SUPPL	2010-09-27
20949	SUPPL	2007-09-26
25820	SUPPL	2006-09-18
35348	SUPPL	2006-08-23
25819	SUPPL	2006-01-06
13427	SUPPL	2004-12-03
3343	SUPPL	2004-12-02
25818	SUPPL	2004-07-01
41698	ORIG	1999-01-27
25817	ORIG	1999-01-27
13426	ORIG	1999-01-27